Merck says Keytruda injection on par with approved IV version in trial

Merck said a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment.

  • Related Posts

    Dozens fall ill with norovirus on month-long cruise

    Over 50 passengers and 15 crew members reported being ill with norovirus on a month-long cruise on the Coral Princess.

    How to capitalize on the November dip-buying opportunity in gold

    Nishant Pant describes a trade set-up in the SPDR Gold Shares.

    Leave a Reply

    Your email address will not be published. Required fields are marked *